HOME / PUBLICATIONS /

Publications

2020
Ouali MA, Ghanai M, Chafaa K. TLBO Optimization Algorithm Based-Type2 Fuzzy Adaptive Filter for ECG Signals Denoising. Traitement du SignalTraitement du Signal. 2020;37.
Ouali MA, Ghanai M, Chafaa K. TLBO Optimization Algorithm Based-Type2 Fuzzy Adaptive Filter for ECG Signals Denoising. Traitement du SignalTraitement du Signal. 2020;37.
Laouicha S, Senator A, Kherbache A, Bouriche H. Total phenolic contents and antioxidant properties of algerian Arbutus unedo L. extracts. Journal of Drug Delivery and TherapeuticsJournal of Drug Delivery and Therapeutics. 2020;10 :159-168.
Laouicha S, Senator A, Kherbache A, Bouriche H. Total phenolic contents and antioxidant properties of algerian Arbutus unedo L. extracts. Journal of Drug Delivery and TherapeuticsJournal of Drug Delivery and Therapeutics. 2020;10 :159-168.
Laouicha S, Senator A, Kherbache A, Bouriche H. Total phenolic contents and antioxidant properties of algerian Arbutus unedo L. extracts. Journal of Drug Delivery and TherapeuticsJournal of Drug Delivery and Therapeutics. 2020;10 :159-168.
Laouicha S, Senator A, Kherbache A, Bouriche H. Total phenolic contents and antioxidant properties of algerian Arbutus unedo L. extracts. Journal of Drug Delivery and TherapeuticsJournal of Drug Delivery and Therapeutics. 2020;10 :159-168.
Aouag S, Kadri S, HEDJAZI D. Towards architectural view-driven modernization. 2020 International Conference on Advanced Aspects of Software Engineering (ICAASE). 2020 :1-6.
Aouag S, Kadri S, HEDJAZI D. Towards architectural view-driven modernization. 2020 International Conference on Advanced Aspects of Software Engineering (ICAASE). 2020 :1-6.
Aouag S, Kadri S, HEDJAZI D. Towards architectural view-driven modernization. 2020 International Conference on Advanced Aspects of Software Engineering (ICAASE). 2020 :1-6.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Morabito F, Gentile M, Monti P, Recchia AG, Menichini P, Skafi M, Atrash M, De Luca G, Bossio S, Al-Janazreh H. TP53 dysfunction in chronic lymphocytic leukemia: clinical relevance in the era of B-cell receptors and BCL-2 inhibitors. Expert Opinion on Investigational DrugsExpert Opinion on Investigational Drugs. 2020;29 :869-880.
Benreguia B, Moumen H, Merzoug MA. Tracking covid-19 by tracking infectious trajectories. Ieee AccessIEEE Access. 2020;8 :145242-145255.

Pages